A Trypanosoma brucei cell line is described that produces a visual readout of 29 proteasome activity. The cell line contains an integrated transgene encoding an 30 ubiquitin-green fluorescent protein (GFP) fusion polypeptide responsive to the 31 addition of proteasome inhibitors. A modified version of T. brucei ubiquitin unable 32 to be recognized by deubiquitinases (UbG76V) was fused to eGFP and 33 constitutively expressed. The fusion protein is unstable but addition of the 34 proteasome inhibitor lactacystin stabilizes it and leads to visually detectable GFP. 35 This cell line can be widely used to monitor the efficiency of inhibitor treatment 36 through detection of GFP accumulation in studies involving proteasome-37 mediated proteolysis, screening of proteasome inhibitors or other events related 38 to the ubiquitin-proteasome pathway. 39 40 Abbreviations: eGFP, enhanced green fluorescent protein; ub, ubiquitin; lact, 42 lactacystin; ORF, open reading frame 43 44 45 46 47 48 49 50 51 Main text 52 53 The proteasome is a multi-catalytic ATP-dependent protease complex that 54 plays a central role in the ubiquitin-mediated proteolysis, the major pathway for 55 regulated degradation of multiple protein targets including cytosolic, nuclear and 56 membrane polypeptides in all eukaryotic organisms 1 . The process of 57 ubiquitination is mediated by three enzymes (E1, E2 and E3) that act in series to 58 generate an isopeptide bond between the carboxyl group of the C-terminal 59 glycine of ubiquitin and the amino group on the side chain of a lysine residue on 60 the substrate. This can then result in degradation of the targeted protein by the 61 proteasome whereas the ubiquitin is recycled following the action of 62 deubiquitinases 2 . 63 The ubiquitin-proteasome system has emerged as a therapeutic target for 64 diverse pathologies such as cancer, neurodegenerative diseases, immune 65 diseases and infections, including those caused by parasites 3 . Proteasome 66 inhibitors are structurally diverse and can interact directly or allosterically with the 67 proteasome active site(s), and can be reversible or irreversible 4 . Lactacystin, a β-68 lactone precursor from natural source, is an example of a potent and specific 69 inhibitor of the proteasome proteolytic activity that binds irreversibly to the 70 catalytic threonines found in the active sites of the proteasome β-subunits 5,6 . 71 Trypanosoma brucei and T. cruzi are the causative agents of African 72 Trypanosomiasis and Chagas disease, respectively, widespread tropical 73 diseases that can be fatal if not treated. Lactacystin as well as other compounds, 74

